Skip to main content Accessibility help
×
Hostname: page-component-848d4c4894-x24gv Total loading time: 0 Render date: 2024-05-15T02:51:22.631Z Has data issue: false hasContentIssue false

Chapter 21 - Chemotherapy and Cardiovascular Function in Pregnancy

from Section 5 - Controversies

Published online by Cambridge University Press:  28 April 2018

Christoph Lees
Affiliation:
Imperial College London
Wilfried Gyselaers
Affiliation:
Hasselt Universiteit, Belgium
Get access
Type
Chapter
Information
Maternal Hemodynamics , pp. 219 - 228
Publisher: Cambridge University Press
Print publication year: 2018

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Gziri, MM, Amant, F, Debieve, F, et al. Effects of chemotherapy during pregnancy on the maternal and fetal heart. Prenat Diagn 2012;32:614–19.Google Scholar
Mulrooney, DA, Yeazel, MW, Kawashima, T, et al. Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort. BMJ 2009;339:b4606.Google Scholar
Trachtenberg, BH, Landy, DC, Franco, VI, et al. Anthracycline-associated cardiotoxicity in survivors of childhood cancer. Pediatr Cardiol 2011;32:342–53.CrossRefGoogle ScholarPubMed
Telli, ML, Hunt, SA, Carlson, RW, Guardino, AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. J Clin Oncol 2007;25:3525–33.CrossRefGoogle ScholarPubMed
Chien, AJ, Rugo, HS. The cardiac safety of trastuzumab in the treatment of breast cancer. Expert Opin Drug Saf 2010;9:335–46.Google Scholar
Sawyer, DB, Peng, X, Chen, B, et al. Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? Prog Cardiovasc Dis 2010;53:105–13.Google Scholar
Abi Aad, S, Pierce, M, Barmaimon, G, et al. Hypertension induced by chemotherapeutic and immunosuppresive agents: a new challenge. Crit Rev Oncol Hematol 2015;93:2835.Google Scholar
Ke, AB, Rostami-Hodjegan, A, Zhao, P, Unadkat, JD. Pharmacometrics in pregnancy: An unmet need. Annu Rev Pharmacol Toxicol 2014;54:5369.CrossRefGoogle ScholarPubMed
Zhao, Y, Hebert, MF, Venkataramanan, R. Basic obstetric pharmacology. Semin Perinatol 2014;38:475–86.CrossRefGoogle ScholarPubMed
van Hasselt, JG, van Calsteren, K, Heyns, L, et al. Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel. Ann Oncol 2014;25:2059–65.Google Scholar
Van Calsteren, K, Verbesselt, R, Ottevanger, N, et al. Pharmacokinetics of chemotherapeutic agents in pregnancy: a preclinical and clinical study. Acta Obstet Gynecol Scand 2010;89:1338–45.Google Scholar
Stensheim, H, Moller, B, van Dijk, T, Fossa, SD. Cause-specific survival for women diagnosed with cancer during pregnancy or lactation: a registry-based cohort study. J Clin Oncol 2009;27:4551.CrossRefGoogle ScholarPubMed
Cardonick, E, Dougherty, R, Grana, G, et al. Breast cancer during pregnancy: maternal and fetal outcomes. Cancer J 2010;16:7682.Google Scholar
Amant, F, von Minckwitz, G, Han, SN, et al. Prognosis of women with primary breast cancer diagnosed during pregnancy: results from an international collaborative study. J Clin Oncol 2013;31:2532–9.CrossRefGoogle ScholarPubMed
Loibl, S, Schmidt, A, Gentilini, O, et al. Breast cancer diagnosed during pregnancy: adapting recent advances in breast cancer care for pregnant patients. JAMA Oncol 2015; 1 (8):1145–53.Google Scholar
Amant, F, Halaska, MJ, Fumagalli, M, et al. Gynecologic cancers in pregnancy: guidelines of a second international consensus meeting. Int J Gynecol Cancer 2014;24:394403.Google Scholar
Van Calsteren, K, Heyns, L, De Smet, F, et al. Cancer during pregnancy: an analysis of 215 patients emphasizing the obstetrical and the neonatal outcomes. J Clin Oncol 2010;28:683–9.CrossRefGoogle ScholarPubMed
Cardonick, E, Iacobucci, A. Use of chemotherapy during human pregnancy. Lancet Oncol 2004;5:283–91.Google Scholar
Juonala, M, Cheung, MM, Sabin, MA, et al. Effect of birth weight on life-course blood pressure levels among children born premature: the Cardiovascular Risk in Young Finns Study. J Hypertens 2015;33:1542–8.Google Scholar
Sipola-Leppanen, M, Vaarasmaki, M, Tikanmaki, M, et al. Cardiometabolic risk factors in young adults who were born preterm. Am J Epidemiol 2015;181:861–73.Google Scholar
Siedner, S, Kruger, M, Schroeter, M, et al. Developmental changes in contractility and sarcomeric proteins from the early embryonic to the adult stage in the mouse heart. J Physiol 2003;548:493505.Google Scholar
Rudolph, AM. Myocardial growth before and after birth: clinical implications. Acta Paediatr 2000;89:129–33.Google Scholar
Germann, N, Goffinet, F, Goldwasser, F. Anthracyclines during pregnancy: embryo-fetal outcome in 160 patients. Ann Oncol 2004;15:146–50.Google Scholar
Achtari, C, Hohlfeld, P. Cardiotoxic transplacental effect of idarubicin administered during the second trimester of pregnancy. Am J Obstet Gynecol 2000;183:511–12.Google Scholar
Reynoso, EE, Huerta, F. Acute leukemia and pregnancy–fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol 1994;33:709–10.Google Scholar
Baumgartner, AK, Oberhoffer, R, Jacobs, VR, et al. Reversible foetal cerebral ventriculomegaly and cardiomyopathy under chemotherapy for maternal AML. Onkologie 2009;32:40–3.Google Scholar
Gziri, MM, Debieve, F, De Catte, L, et al. Chemotherapy during pregnancy: effect of anthracyclines on fetal and maternal cardiac function. Acta Obstet Gynecol Scand 2012;91:1465–8.Google Scholar
Meyer-Wittkopf, M, Barth, H, Emons, G, Schmidt, S. Fetal cardiac effects of doxorubicin therapy for carcinoma of the breast during pregnancy: case report and review of the literature. Ultrasound Obstet Gynecol 2001;18:62–6.Google Scholar
Amant, F, Vandenbroucke, T, Verheecke, M, et al. Pediatric Outcome after Maternal Cancer Diagnosed during Pregnancy. N Engl J Med 2015; 373(19):1824–34.CrossRefGoogle ScholarPubMed
Aviles, A, Neri, N, Nambo, MJ. Long-term evaluation of cardiac function in children who received anthracyclines during pregnancy. Ann Oncol 2006;17:286–8.CrossRefGoogle ScholarPubMed
Gziri, MM, Hui, W, Amant, F, et al. Myocardial function in children after fetal chemotherapy exposure. A tissue Doppler and myocardial deformation imaging study. Eur J Pediatr 2013;172:163–70.Google Scholar
Van Calsteren, K, Verbesselt, R, Beijnen, J, et al. Transplacental transfer of anthracyclines, vinblastine, and 4-hydroxy-cyclophosphamide in a baboon model. Gynecol Oncol 2010;119:594600.Google Scholar
Grohard, P, Akbaraly, JP, Saux, MC, et al. Transplacental passage of doxorubicin. J Gynecol Obstet Biol Reprod (Paris) 1989;18:595600.Google Scholar
Gaillard, B, Leng, JJ, Grellet, J, et al. Transplacental passage of epirubicin. J Gynecol Obstet Biol Reprod (Paris) 1995;24:63–8.Google Scholar
Pearson, GD, Veille, JC, Rahimtoola, S, et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 2000;283:1183–8.Google Scholar
van Dalen, EC, van der Pal, HJ, van den Bos, C, et al. Clinical heart failure during pregnancy and delivery in a cohort of female childhood cancer survivors treated with anthracyclines. Eur J Cancer 2006;42:2549–53.Google Scholar
Krischer, JP, Epstein, S, Cuthbertson, DD, et al. Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience. J Clin Oncol 1997;15:1544–52.CrossRefGoogle ScholarPubMed
Silber, JH, Jakacki, RI, Larsen, RL, et al. Increased risk of cardiac dysfunction after anthracyclines in girls. Med Pediatr Oncol 1993;21:477–9.Google Scholar
Katz, A, Goldenberg, I, Maoz, C, et al. Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin. Am J Med Sci 1997;314:399400.Google Scholar
Bar, J, Davidi, O, Goshen, Y, et al. Pregnancy outcome in women treated with doxorubicin for childhood cancer. Am J Obstet Gynecol 2003;189:853–7.Google Scholar
Hines, MR, Mulrooney, DA, Hudson, MM, et al. Pregnancy-associated cardiomyopathy in survivors of childhood cancer. J Cancer Surviv 2016;10(1):113–21.Google Scholar
Altena, R, Gietema, JA, van Veldhuisen, DJ, Reyners, AK. Pregnancy unbosoms the heart of breast cancer survivors. Ann Oncol 2012;23:2206–8.Google Scholar
European Society of Gynecology (ESG), Association for European Paediatric Cardiology (AEPC), German Society for Gender Medicine (DGesGM), et al. ESC Guidelines on the management of cardiovascular diseases during pregnancy: the Task Force on the Management of Cardiovascular Diseases during Pregnancy of the European Society of Cardiology (ESC). Eur Heart J 2011;32:3147–97.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×